https://www.selleckchem.com/pr....oducts/tipranavir.ht
54), PLT (r = 0.61), and hemoglobin (r = -0.35; all Ps 0.7), with FCT being the best (0.91) for endoscopically active disease. Combining FCT and FIT improved the specificity to 95%, but the sensitivity decreased to 65.4%. In the subgroup analysis of UC, adding PLT to FIT improved the sensitivity and specificity to 100% and 90.9%, respectively. DISCUSSION The combined use of fecal biomarkers and blood indexes is superior to the use of fecal biomarkers alone in identifying endoscopically active disease.BACKGROUND Deformity of the tibia
Like
Comment
Share
